Comparison of incidence of hyponatremia between linezolid and vancomycin in neonates and infants

被引:0
作者
Shibata, Yuichi [1 ,2 ]
Hirai, Jun [1 ,3 ]
Mori, Nobuaki [1 ,3 ]
Asai, Nobuhiro [1 ,3 ]
Hagihara, Mao [4 ]
Yamada, Yasumasa [5 ]
Mikamo, Hiroshige [1 ,3 ]
机构
[1] Aichi Med Univ Hosp, Dept Infect Prevent & Control, Nagakute, Aichi, Japan
[2] Aichi Med Univ Hosp, Dept Pharm, Nagakute, Aichi, Japan
[3] Aichi Med Univ Hosp, Dept Clin Infect Dis, Nagakute, Aichi, Japan
[4] Aichi Med Univ, Dept Mol Epidemiol & Biomed Sci, Nagakute, Aichi, Japan
[5] Aichi Med Univ, Dept Perinatal & Neonatal Med, Nagakute, Aichi, Japan
关键词
Neonates; Infants; Linezolid; Vancomycin; Hyponatremia; RISK-FACTORS;
D O I
10.1016/j.jiac.2024.09.014
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A previous study reported that the incidence of hyponatremia after linezolid (LZD) use was higher than that with vancomycin (VCM) use in adults. However, hyponatremia due to LZD in neonates and infants was not investigated. This study aimed to compare the incidence of hyponatremia between LZD and VCM use in neonates and infants. The retrospective study was conducted at the Aichi Medical University Hospital. All patients who were cared for in NICU or GCU and received >3 days of LZD or VCM were included in this study. Hyponatremia was defined as serum sodium level <= 134 mEq/L and >5 % decrease from baseline after administration of LZD or VCM. A total of 76 patients (LZD, N = 36; VCM, N = 37) were included. There was no significant difference in the incidence of hyponatremia between the two groups (19.4% vs 16.2 %, p = 0.72). The proportion of patients with a minimum value of serum sodium <= 134 mEq/L during treatment was 47.3% in the LZD group and 35.1 % in the VCM group (p = 0.29), and the decrease in serum sodium level from baseline to the minimum value was 80.5 % and 78.4 %, respectively (p = 0.85). In conclusion, there was no significant difference in the incidence of hyponatremia between the LZD and VCM groups. Therefore, it is not necessary to avoid LZD use in neonates and infants because of the risk of hyponatremia.
引用
收藏
页数:5
相关论文
共 14 条
[1]  
Moellering R.C., Linezolid: the first oxazolidinone antimicrobial, Ann Intern Med, 138, pp. 135-142, (2003)
[2]  
Wu V.-C., Wang Y.-T., Wang C.-Y., Tsai I.-J., Wu K.-D., Hwang J.-J., Et al., High frequency of linezolid-associated thrombocytopenia and anemia among patients with end-stage renal disease, Clin Infect Dis, 42, pp. 66-72, (2006)
[3]  
Flanagan S., McKee E.E., Das D., Tulkens P.M., Hosako H., Fiedler-Kelly J., Et al., Nonclinical and pharmacokinetic assessments to evaluate the potential of tedizolid and linezolid to affect mitochondrial function, Antimicrob Agents Chemother, 59, pp. 178-185, (2015)
[4]  
Shibata Y., Yamagishi Y., Mikamo H., Kato H., Nishiyama N., Asai N., Et al., Comparative study on safety of linezolid and vancomycin in the treatment of infants and neonates for Gram-positive bacterial infections, J Infect Chemother, 24, pp. 695-701, (2018)
[5]  
Tanaka R., Morinaga Y., Iwao M., Tatsuta R., Hashimoto T., Hiramatsu K., Et al., Comparison of incidence of hyponatremia between linezolid and vancomycin by propensity score matching analysis, Biol Pharm Bull, 46, pp. 1365-1370, (2023)
[6]  
Nishi Y., Ogami C., Tsuji Y., Kawasuji H., Yamada H., Kawai S., Et al., Evaluation of the relationship between linezolid exposure and hyponatremia, J Infect Chemother, 27, pp. 165-171, (2021)
[7]  
Shibata Y., Hagihara M., Asai N., Shiota A., Hirai J., Mori N., Et al., A retrospective study to compare the incidence of hyponatremia after administration between linezolid and tedizolid, Antibiotics (Basel), 12, (2023)
[8]  
Tanaka R., Suzuki Y., Takumi Y., Iwao M., Sato Y., Hashinaga K., Et al., A retrospective analysis of risk factors for linezolid-associated hyponatremia in Japanese patients, Biol Pharm Bull, 39, pp. 1968-1973, (2016)
[9]  
Tanaka R., Suzuki Y., Morinaga Y., Iwao M., Takumi Y., Hashinaga K., Et al., A retrospective test for a possible relationship between linezolid-induced thrombocytopenia and hyponatraemia, J Clin Pharm Therapeut, 46, pp. 343-351, (2021)
[10]  
Chowdhury A.S., Rahman M.E., Hossain F., Md Parvez A.F., Hassan M.K., Munmun F., Et al., Association of serum electrolyte abnormalities in preterm low birth weight neonates, Faridpur Med Coll J, 14, pp. 31-33, (2020)